On September 1, 2025, the application window opened to join the 2026 NHS Innovation Accelerator (NIA) program. NIA supports the development of innovators (Fellows) and the spread of their innovation nationally. The 2026 call is not limited to a specific theme and is open to innovations addressing any health and care challenges. The application deadline is October 12, 2025.

MTRC is pleased to present the 2025 EU Prioritization Matrix for Hospital Medical Devices - your annual, refresh-and-reuse guide to strategic market entry across Europe.

On September 6, 2025, the Ministry of Labor, Health, Solidarity and Families authorized a two-year experiment on the reprocessing of certain single-use medical devices used in the cardiology field, including cardiac electrophysiology and mapping, cardiac ablation, angiography devices, and ultrasound catheters. The experiment aims to assess the technical feasibility, safety, economic impact, and environmental benefits of this practice, with a view to its permanent establishment and expansion. The experiment will start on January 1, 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, van Nieuwenhuizen et al. systematically reviewed the environmental impact of operating rooms, focusing on surgical techniques, device use, cover materials, anesthesia, and ventilation.

In September 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the list of reimbursable companion diagnostics. A new clinical indication, urothelial carcinoma, was introduced, with two new predictive biomarker tests included in the List.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Saing et al. used a simulation study with a Sick-Sicker Markov model to explore how subgroup heterogeneity influences cost-effectiveness and reimbursement decisions.

In August 2025, the National Institute for Health and Care Research (NIHR) in England released three Med Tech-related assessments in its HTA Journal, which concerned nephrology and urology, endocrinology, radiotherapy, and neurosurgery fields.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Pimenta et al. systematically reviewed approaches for selecting and prioritizing medical devices for health technology assessment (HTA).

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of September 08th, we plan to work on 25 projects. Review the complete list of planned activities in this post.

On August 21, 2025, NHS England published an updated work plan for the development of Clinical Commissioning Policies for specialised services. One new MedTech-related policy concerning renal denervation for resistant hypertension was added to the work program, and none have been published since the previous update. The status of ongoing policies has also been updated.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Eussen et al. conducted a global survey on surgeons’ perspectives regarding disposable and reusable surgical materials in laparoscopic cholecystectomy.

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the August 2025 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Four favourable opinions were issued concerning add-on reimbursement for medical devices in the cardiovascular, ENT, and neuromodulation fields.